Skip to main content
Livermore
Livermore
ZHEN

Enzo Biochem Inc

ENZBDelisted Apr 7, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000316253

Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Enzo Biochem Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
−5 vs. Q1 2023
Shares held
18.8M
−995.5K (−5.0%) vs. Q1 2023
Total value
$34.7M
−$13.4M (−27.9%) vs. Q1 2023
New holders
5
9 more added
Sold out
10
13 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 47 institutions
Q1 2021: 82 institutionsQ2 2021: 72 institutionsQ3 2021: 65 institutionsQ4 2021: 59 institutionsQ1 2022: 51 institutionsQ2 2022: 54 institutionsQ3 2022: 49 institutionsQ4 2022: 52 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 39 institutionsQ4 2023: 46 institutionsQ1 2024: 41 institutionsQ2 2024: 39 institutionsQ3 2024: 43 institutionsQ4 2024: 44 institutionsQ1 2025: 41 institutionsQ2 2025: 7 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $34.7M
Q1 2021: $94.6MQ2 2021: $76.6MQ3 2021: $82.9MQ4 2021: $69.0MQ1 2022: $62.0MQ2 2022: $43.8MQ3 2022: $45.6MQ4 2022: $26.8MQ1 2023: $48.1MQ2 2023: $34.7MQ3 2023: $23.1MQ4 2023: $22.7MQ1 2024: $17.6MQ2 2024: $13.5MQ3 2024: $14.2MQ4 2024: $9.71MQ1 2025: $4.96MQ2 2025: $2.00MQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ENZB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20257$2.00M
Q1 202541$4.96M
Q4 202444$9.71M
Q3 202443$14.2M
Q2 202439$13.5M
Q1 202441$17.6M
Q4 202346$22.7M
Q3 202339$23.1M
Q2 202347$34.7M
Q1 202352$48.1M
Q4 202252$26.8M
Q3 202249$45.6M
Q2 202254$43.8M
Q1 202251$62.0M
Q4 202159$69.0M
Q3 202165$82.9M
Q2 202172$76.6M
Q1 202182$94.6M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q1 2023.

Institutions holding ENZB in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
GWM Advisors LLC10$180.00%00.0%Unchanged
Focused Wealth Management, Inc110$2020.00%00.0%Unchanged
Benjamin Edwards Inc300$1.00K0.00%00.0%Unchanged
UBS Group AG619$1.14K0.00%+619New
Advisor Group Holdings, Inc.1,003$1.84K0.00%00.0%Unchanged
Royal Bank of Canada1,182$2.00K0.00%+182+18.2%Added
Wells Fargo & Company1,275$2.35K0.00%+16+1.3%Added
JPMorgan Chase & Co1,833$3.37K0.00%00.0%Unchanged
Bank of America Corp3,088$5.68K0.00%00.0%Unchanged
BDO Wealth Advisors, LLC5,000$9.20K0.00%00.0%Unchanged
Citadel Advisors LLC6,046$11.1K0.00%−16,837−73.6%Reduced
Tower Research Capital LLC (TRC)9,909$18.2K0.00%+3,105+45.6%Added
Wealth Alliance11,033$20.3K0.00%−400−3.5%Reduced
Simplex Trading, LLC11,705$21.0K0.00%−77,192−86.8%Reduced
Occudo Quantitative Strategies LP11,534$21.2K0.00%+11,534New
Charles Schwab Investment Management Inc13,471$24.8K0.00%00.0%Unchanged
Shulman DeMeo Asset Management LLC15,487$28.5K0.01%00.0%Unchanged
Cutter & CO Brokerage, Inc.15,500$28.5K0.01%00.0%Unchanged
Agate Pass Investment Management, LLC16,292$30.0K0.02%+16,292New
Raymond James Trust N.A.17,016$31.0K0.00%00.0%Unchanged
Paradigm Financial Partners, LLC19,500$35.9K0.01%00.0%Unchanged
Centiva Capital, LP19,610$36.1K0.00%+19,610New
AE Wealth Management LLC20,000$36.8K0.00%00.0%Unchanged
Snowden Capital Advisors LLC22,699$41.8K0.00%+200+0.9%Added
Sage Mountain Advisors LLC23,362$43.0K0.01%+23,362New
Kempner Capital Management Inc.25,475$47.0K0.03%00.0%Unchanged
Bank of New York Mellon Corp26,217$48.2K0.00%00.0%Unchanged
Price T Rowe Associates Inc44,800$83.0K0.00%00.0%Unchanged
Corsair Capital Management, L.P.47,726$87.8K0.03%−6,760−12.4%Reduced
Lazard Asset Management LLC50,453$92.0K0.00%00.0%Unchanged
Morgan Stanley67,639$124.5K0.00%−103,241−60.4%Reduced
Fifth Lane Capital, LP85,000$156.4K0.15%+30,139+54.9%Added
Northern Trust Corp104,580$192.4K0.00%+2,165+2.1%Added
State Street Corp167,039$307.4K0.00%−17,100−9.3%Reduced
Assenagon Asset Management S.A.181,862$334.6K0.00%+105,642+138.6%Added
RBF Capital, LLC250,359$460.7K0.03%00.0%Unchanged
Bridgeway Capital Management, LLC309,399$569.3K0.01%−6,101−1.9%Reduced
Geode Capital Management, LLC337,575$621.1K0.00%−17,467−4.9%Reduced
Roumell Asset Management, LLC681,358$1.25M2.46%−223,954−24.7%Reduced
Fuller & Thaler Asset Management, Inc.985,660$1.81M0.01%+3,125+0.3%Added
BlackRock Inc.998,479$1.84M0.00%−421,909−29.7%Reduced
Potomac Capital Management, Inc.1,049,900$1.93M2.68%+269,391+34.5%Added
Dimensional Fund Advisors LP1,267,075$2.33M0.00%−254,608−16.7%Reduced
Vanguard Group Inc1,729,084$3.18M0.00%−42,587−2.4%Reduced
Tang Capital Management LLC2,300,000$4.23M0.62%00.0%Unchanged
Renaissance Technologies LLC2,704,864$4.98M0.01%−65,200−2.4%Reduced
Harbert Fund Advisors, Inc.5,175,913$9.52M6.11%00.0%Unchanged
Millennium Management LLC0$00.00%−70,685−100.0%Sold out
Jane Street Group, LLC0$00.00%−27,023−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−19,985−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−18,643−100.0%Sold out
IFG Advisory, LLC0$00.00%−16,250−100.0%Sold out
Baird Financial Group, Inc.0$00.00%−15,000−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−11,003−100.0%Sold out
Advisory Services Network, LLC0$00.00%−500−100.0%Sold out
City Holding Co0$00.00%−120−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−48,309−100.0%Sold out